Grown Rogue International (GRUSF) Cash from Operations Growth (1y) (2014 - 2026)
Grown Rogue International (GRUSF) Cash from Operations Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.46% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 425.00% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 352.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 352.30% |
| Dec 31, 2025 | -15,247,565.85% |
| Mar 31, 2025 | -200.89% |
| Jan 31, 2023 | 967.93% |
| Jan 31, 2022 | -51.30% |
| Oct 31, 2021 | 138,485,601.63% |
| Jul 31, 2021 | -770.42% |
| Apr 30, 2021 | 375.28% |
| Jan 31, 2021 | -17.94% |
| Oct 31, 2020 | 94.31% |
| Jul 31, 2020 | -103.33% |
| Apr 30, 2020 | 247.43% |
| Jan 31, 2020 | 106.93% |
| Oct 31, 2019 | -11,789.50% |
| Jul 31, 2019 | 1,111.80% |
| Apr 30, 2019 | 90.10% |
| Jan 31, 2019 | -135.42% |
| May 31, 2018 | 85.61% |
| May 31, 2017 | 40.80% |
| Nov 30, 2016 | -374.83% |